NEVVI Medicare utilization intelligence
or browse by specialty
Medicare · fee-for-service Part B

Rheumatology — Medicare Part B billing by state

$0.70B
Medicare payments
202
Physician groups
63,948,405
Services

202 physician groups whose primary specialty is Rheumatology billed $0.70B to Medicare fee-for-service in 2024.

Calendar year 2024 · Medicare fee-for-service Part B

Physician groups whose primary specialty is Rheumatology, by billing state · CY2024
State Groups Services Beneficiary-episodes Medicare payments Standardized payments ↓ Payments / group Services / group
Florida 22 9,907,341 197,180 $99,784,979 $98,417,169 $4,535,681 450,334
California 27 5,753,785 188,101 $65,124,161 $62,881,320 $2,412,006 213,103
Arizona 5 4,433,100 111,056 $49,646,726 $49,466,235 $9,929,345 886,620
South Carolina 9 3,723,540 77,471 $40,356,397 $40,958,219 $4,484,044 413,727
North Carolina 11 2,857,666 69,586 $32,042,006 $32,180,992 $2,912,910 259,788
New York 10 2,461,082 119,699 $32,268,086 $31,379,964 $3,226,809 246,108
Texas 23 3,069,903 109,941 $31,177,346 $31,354,146 $1,355,537 133,474
Maryland 9 2,626,004 84,916 $30,588,733 $29,896,537 $3,398,748 291,778
Pennsylvania 11 2,299,881 46,732 $28,005,509 $27,531,346 $2,545,955 209,080
New Jersey 6 2,459,159 53,151 $26,976,056 $26,429,656 $4,496,009 409,860
Virginia 11 2,473,267 44,858 $23,788,521 $23,552,397 $2,162,593 224,842
Georgia 10 1,961,603 56,374 $21,215,214 $21,262,376 $2,121,521 196,160
Alabama 5 1,531,562 59,830 $20,698,171 $20,970,119 $4,139,634 306,312
Kentucky 6 1,944,870 24,459 $16,779,011 $17,161,986 $2,796,502 324,145
Kansas 3 1,431,110 36,146 $14,922,366 $14,996,464 $4,974,122 477,037
Tennessee 6 1,375,028 36,809 $14,669,617 $14,973,328 $2,444,936 229,171
Louisiana 4 1,057,996 23,587 $12,864,986 $13,030,891 $3,216,247 264,499
Indiana 8 1,217,982 27,160 $12,259,559 $12,357,581 $1,532,445 152,248
Missouri 1 1,097,395 28,944 $12,021,814 $12,142,068 $12,021,814 1,097,395
Ohio 5 1,023,283 29,875 $11,071,609 $11,171,962 $2,214,322 204,657
Colorado 3 905,456 15,070 $10,406,979 $10,360,228 $3,468,993 301,819
Illinois 5 1,083,409 30,599 $10,107,848 $10,087,943 $2,021,570 216,682
Iowa 2 785,750 43,166 $9,536,720 $9,576,178 $4,768,360 392,875
Minnesota 3 700,236 26,498 $9,408,733 $9,442,349 $3,136,244 233,412
Oregon 3 688,249 16,372 $9,305,387 $9,352,242 $3,101,796 229,416
Oklahoma 1 815,408 13,993 $8,494,198 $8,602,517 $8,494,198 815,408
Arkansas 3 764,992 8,672 $8,348,799 $8,453,355 $2,782,933 254,997
Michigan 7 629,265 15,763 $7,806,567 $7,944,358 $1,115,224 89,895
Wisconsin 3 530,018 30,996 $7,619,719 $7,675,827 $2,539,906 176,673
Idaho 2 363,254 10,049 $4,694,925 $4,797,152 $2,347,462 181,627
Massachusetts 3 280,620 22,890 $3,605,994 $3,530,443 $1,201,998 93,540
Washington 2 300,814 4,150 $3,009,368 $2,961,746 $1,504,684 150,407
New Mexico 1 240,304 2,121 $2,687,512 $2,724,620 $2,687,512 240,304
Rhode Island 2 300,721 3,375 $2,413,810 $2,381,944 $1,206,905 150,360
District of Columbia 3 193,725 8,560 $2,083,583 $2,001,391 $694,528 64,575
Utah 2 376,705 2,118 $1,727,566 $1,728,480 $863,783 188,352
Nevada 1 133,731 2,484 $1,440,278 $1,457,897 $1,440,278 133,731
Connecticut 5 72,309 6,198 $1,351,735 $1,284,063 $270,347 14,462
Maine 1 76,716 3,374 $522,959 $519,620 $522,959 76,716
New Hampshire 1 677 497 $35,979 $38,808 $35,979 677
Alaska 1 172 127 $24,883 $26,479 $24,883 172
PR 1 316 183 $22,813 $24,026 $22,813 316
Ranked by standardized payments — the cross-state basis (regional price differences removed). The Medicare payments column shows what Medicare actually paid. Each state opens the ranked Rheumatology market for that state's biggest code.

Need this specialty's market in one document?

Notify me at launch

Each group carries one specialty label — the specialty most common among its clinicians in CMS's Doctors and Clinicians register — so every figure on this page counts groups, not individual clinicians. An organization's entire Medicare billing is credited to that one label, so a specialty's totals reflect how organizations are labeled, not the specialty of each service; large multi-specialty organizations — where no single specialty is a majority of the clinicians — account for much of the volume shown under many specialties. Totals include only volume that can be credited to a single group; clinicians registered with more than one group are left out of group totals and shown as “—” elsewhere on Nevvi. Clinicians not registered with any group, and groups without a specialty label, are also not included. A group is counted in every state its clinicians bill Medicare from, so state figures overlap and never sum to the national figure.

All figures are Medicare fee-for-service Part B only; Medicare Advantage claims are not included. Cross-state comparisons use standardized payments, which remove regional differences in what Medicare pays; services without a standardized amount — mainly Part B drugs — are not in that column, and the Medicare payments column shows what Medicare actually paid. Beneficiary counts are beneficiary-episodes: one person treated in more than one setting or state is counted in each.

Top codes by Medicare payments CY2024

Code Services Medicare payments ↓ Largest state markets
J0129 · Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) 4,582,912 $154,007,112 FLCAAZSCNC
J0897 · Injection, denosumab, 1 mg 4,417,594 $90,209,790 FLCAAZSCNC
J0717 · Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) 21,408,241 $76,898,999 FLCAAZSCNC
J1602 · Injection, golimumab, 1 mg, for intravenous use 7,117,657 $63,999,508 FLCAAZSCNC
J3262 · Injection, tocilizumab, 1 mg 12,889,713 $60,184,810 FLCAAZSCNC
99214 · Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more 480,779 $44,187,473 FLCAAZSCNC
J3111 · Injection, romosozumab-aqqg, 1 mg 4,826,010 $40,685,977 FLCAAZSCNC
J1745 · Injection, infliximab, excludes biosimilar, 10 mg 1,453,154 $35,700,623 FLCAAZSCNC
J9312 · Injection, rituximab, 10 mg 405,213 $24,453,055 FLCAAZSCNC
96413 · Administration of chemotherapy into vein, 1 hour or less 174,866 $17,514,327 FLCAAZSCNC
J1010 · Injection, methylprednisolone acetate, 1 mg top by services 1,378,912 $139,072 FLCAAZSCNC
Top codes by Medicare payments and by services (both rankings, duplicates merged; capped, never the full code list). “top by services” marks codes here on service volume rather than payments. Each code is searchable free at full depth; state links open that code's ranked market page.

Every code above is searchable free at full depth. Ranking organizations across several codes at once — one combined market view — is part of a Nevvi subscription.

Notify me at launch